Interleukin-4 and breast cancer

Breast Cancer. 2000;7(3):181-6. doi: 10.1007/BF02967457.

Abstract

IL-4 is a pleiotropic cytokine produced by T lymphocytes which acts on various cells of such as T and B lymphocytes, monocytes, fibroblast, endothelial cells, macrophages and some others. IL-4 was originally described as a B cell growth factor, and now known to provide potent anti-tumor activity against various tumors, including breast cancer. IL-4 can induce apoptosis in cultured breast cancer cells. In addition, it has been clarified that IL-4 plays an important role in the regulation of estrogen synthesis enzymes including 17beta-HSD and 3beta-HSD. These findings imply that IL-4 is a key enzyme not only for Th2 type immune reactions but also for tumor cell growth itself in human breast cancer.

Publication types

  • Review

MeSH terms

  • Apoptosis / drug effects
  • Apoptosis / physiology
  • Breast Neoplasms / enzymology
  • Breast Neoplasms / immunology*
  • Breast Neoplasms / therapy*
  • Estrogens / physiology
  • Humans
  • Interleukin-4 / physiology*
  • Interleukin-4 / therapeutic use*
  • Lymphocytes / drug effects
  • Lymphocytes / physiology
  • Receptors, Interleukin-4 / physiology*
  • Th2 Cells / drug effects
  • Th2 Cells / physiology
  • Treatment Outcome
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / physiology

Substances

  • Estrogens
  • Receptors, Interleukin-4
  • Interleukin-4